Bio-Rad Laboratories

Bio-Rad Laboratories BIO Stock

$370.17   3.344600%
Add to favorites
Exchange
Market Cap
$9.95B
LOW - HIGH [24H]
$358.38 - $370.65
VOLUME [24H]
$460.47K
P/E Ratio
9.83
Earnings per share
$37.64
ISIN
US0905722072
Price   Prediction

Bio-Rad Laboratories Price Chart

Sorry, that's all we've gotfor now...

Bio-Rad Laboratories (BIO) stock price today is 370.17 USD on NYSE (+3.34% on the day). Updated .

Bio-Rad Laboratories BIO Financial and Trading Overview

Bio-Rad Laboratories stock price 370.17 USD
Previous Close 360.26 USD
Open 359.39 USD
Bid 0 USD x 4000
Ask 0 USD x 48000
Day's Range 356.58 - 361.69 USD
52 Week Range 236.73 - 396.23 USD
Volume 202.63K USD
Avg. Volume 255.66K USD
Market Cap 9.63B USD
Beta (5Y Monthly) 1.057
PE Ratio (TTM) 9.516207
EPS (TTM) 37.64 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 356.67 USD

BIO Valuation Measures

Enterprise Value 9.33B USD
Trailing P/E 9.516207
Forward P/E 36.15645
PEG Ratio (5 yr expected) 4.01
Price/Sales (ttm) 3.7153485
Price/Book (mrq) 1.2668754
Enterprise Value/Revenue 3.599
Enterprise Value/EBITDA 22.711

Trading Information

Bio-Rad Laboratories Stock Price History

Beta (5Y Monthly) 1.057
52-Week Change 17.52%
S&P500 52-Week Change 10.51%
52 Week High 396.23 USD
52 Week Low 236.73 USD
50-Day Moving Average 372 USD
200-Day Moving Average 317.63 USD

BIO Share Statistics

Avg. Volume (3 month) 255.66K USD
Avg. Daily Volume (10-Days) 277.05K USD
Shares Outstanding 21.83M
Float 21.51M
Short Ratio 5.09
% Held by Insiders 16.28%
% Held by Institutions 89.84%
Shares Short 1.16M
Short % of Float 7.20%
Short % of Shares Outstanding 4.29%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 39.45%
Operating Margin (ttm) 9.45%
Gross Margin 52.18%
EBITDA Margin 15.84%

Management Effectiveness

Return on Assets (ttm) 1.49%
Return on Equity (ttm) 14.26%

Income Statement

Revenue (ttm) 2.59B USD
Revenue Per Share (ttm) 96.45 USD
Quarterly Revenue Growth (yoy) 0.50%
Gross Profit (ttm) 1.35B USD
EBITDA 410.9M USD
Net Income Avi to Common (ttm) 1.02B USD
Diluted EPS (ttm) 37.64
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.66B USD
Total Cash Per Share (mrq) 61.89 USD
Total Debt (mrq) 1.36B USD
Total Debt/Equity (mrq) 17.93 USD
Current Ratio (mrq) 3.177
Book Value Per Share (mrq) 282.735

Cash Flow Statement

Operating Cash Flow (ttm) 468.1M USD
Levered Free Cash Flow (ttm) 271.65M USD

Profile of Bio-Rad Laboratories

Country United States
State CA
City Hercules
Address 1000 Alfred Nobel Drive
ZIP 94547
Phone 510 724 7000
Website https://www.bio-rad.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 7450

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Q&A For Bio-Rad Laboratories Stock

What is a current BIO stock price?

Bio-Rad Laboratories BIO stock price today per share is 370.17 USD.

How to purchase Bio-Rad Laboratories stock?

You can buy BIO shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bio-Rad Laboratories?

The stock symbol or ticker of Bio-Rad Laboratories is BIO.

Which industry does the Bio-Rad Laboratories company belong to?

The Bio-Rad Laboratories industry is Medical Devices.

How many shares does Bio-Rad Laboratories have in circulation?

The max supply of Bio-Rad Laboratories shares is 26.89M.

What is Bio-Rad Laboratories Price to Earnings Ratio (PE Ratio)?

Bio-Rad Laboratories PE Ratio is 9.83448500 now.

What was Bio-Rad Laboratories earnings per share over the trailing 12 months (TTM)?

Bio-Rad Laboratories EPS is 37.64 USD over the trailing 12 months.

Which sector does the Bio-Rad Laboratories company belong to?

The Bio-Rad Laboratories sector is Healthcare.

Bio-Rad Laboratories BIO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us S&P 500 INDEX SPX US 7323.63 USD —
-0.23
3.09B USD — — — — — — 3.09B USD —
us S&P 500 (Yahoo.com) GSPC US 7323.63 USD —
-0.23
3.06B USD — 7285.76 USD — 7367.68 USD — — 3.06B USD —
us NYSE Composite Index NYA US 23559.61 USD —
-1.06
— — — — — — — — —
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
— — 2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD — — —
$2.19T
Total marketcap
$73.33B
Total volume
BTC 58.06%   •   ETH 10.02%
Dominance
Select currency